TATVA — Tatva Chintan Pharma Chem Balance Sheet
0.000.00%
- IN₹34.08bn
- IN₹34.74bn
- IN₹3.83bn
- 78
- 4
- 100
- 68
Annual balance sheet for Tatva Chintan Pharma Chem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 64.8 | 638 | 412 | 457 | 117 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 926 | 694 | 968 | 881 | 1,086 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,843 | 4,359 | 3,123 | 2,979 | 2,652 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,302 | 2,108 | 4,265 | 4,995 | 5,471 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,148 | 6,583 | 7,589 | 8,187 | 8,362 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,180 | 1,714 | 2,387 | 797 | 960 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,488 | 1,852 | 2,441 | 816 | 974 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,660 | 4,731 | 5,148 | 7,371 | 7,388 |
| Total Liabilities & Shareholders' Equity | 3,148 | 6,583 | 7,589 | 8,187 | 8,362 |
| Total Common Shares Outstanding |